CN Patent

CN101132780A — 缓慢释放取代的吡嗪化合物的剂型和方法

Assigned to Jazz Pharmaceuticals Inc · Expires 2008-02-27 · 18y expired

What this patent protects

本发明涉及以缓慢释放的方式给予治疗剂，以在使与该治疗剂有关的副作用降至最低的条件下提供预期疗效的剂型和方法。该治疗剂选自取代的吡嗪化合物的组，并且可以是(3)－(2，3，5－三氯－苯基)－吡嗪－(2，6)－二胺。

USPTO Abstract

本发明涉及以缓慢释放的方式给予治疗剂，以在使与该治疗剂有关的副作用降至最低的条件下提供预期疗效的剂型和方法。该治疗剂选自取代的吡嗪化合物的组，并且可以是(3)－(2，3，5－三氯－苯基)－吡嗪－(2，6)－二胺。

Drugs covered by this patent

sodium-oxybate (SODIUM OXYBATE)

Patent Metadata

Patent number: CN101132780A
Jurisdiction: CN
Classification: —
Expires: 2008-02-27
Drug substance claim: No
Drug product claim: No
Assignee: Jazz Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.